Annual SG&A:
$0.00-$120.94M(-100.00%)Summary
- As of today, CPRX annual SG&A is $0.00, with the most recent change of -$120.94 million (-100.00%) on December 31, 2024.
- During the last 3 years, CPRX annual SG&A has fallen by -$45.17 million (-100.00%).
- CPRX annual SG&A is now -100.00% below its all-time high of $120.94 million, reached on December 31, 2023.
Performance
CPRX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$39.26M-$2.23M(-5.38%)Summary
- As of today, CPRX quarterly SG&A is $39.26 million, with the most recent change of -$2.23 million (-5.38%) on June 30, 2025.
- Over the past year, CPRX quarterly SG&A has increased by +$2.53 million (+6.89%).
- CPRX quarterly SG&A is now -6.22% below its all-time high of $41.86 million, reached on September 30, 2024.
Performance
CPRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
$1.25B+$208.66M(+20.03%)Summary
- As of today, CPRX TTM SG&A is $1.25 billion, with the most recent change of +$208.66 million (+20.03%) on June 30, 2025.
- Over the past year, CPRX TTM SG&A has increased by +$1.11 billion (+766.75%).
- CPRX TTM SG&A is now at all-time high.
Performance
CPRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
CPRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | +6.9% | +766.8% |
| 3Y3 Years | -100.0% | +246.8% | +2424.8% |
| 5Y5 Years | -100.0% | +315.0% | +3197.0% |
CPRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -6.2% | +212.5% | at high | +7965.4% |
| 5Y | 5-Year | -100.0% | at low | -6.2% | +340.8% | at high | +397.3% |
| All-Time | All-Time | -100.0% | at low | -6.2% | >+9999.0% | at high | +302.3% |
CPRX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $39.26M(-5.4%) | $162.09M(+1.6%) |
| Mar 2025 | - | $41.49M(+5.1%) | $159.56M(+1.5%) |
| Dec 2024 | $0.00(-100.0%) | $39.49M(-5.7%) | $157.27M(+0.8%) |
| Sep 2024 | - | $41.86M(+14.0%) | $155.99M(+8.1%) |
| Jun 2024 | - | $36.73M(-6.3%) | $144.25M(+8.5%) |
| Mar 2024 | - | $39.20M(+2.6%) | $132.97M(+10.0%) |
| Dec 2023 | $120.94M(+132.6%) | $38.20M(+26.8%) | $120.94M(+26.1%) |
| Sep 2023 | - | $30.12M(+18.4%) | $95.90M(+22.4%) |
| Jun 2023 | - | $25.45M(-6.3%) | $78.34M(+22.0%) |
| Mar 2023 | - | $27.16M(+106.4%) | $64.21M(+23.5%) |
| Dec 2022 | $52.01M(+15.1%) | $13.16M(+4.8%) | $52.01M(+1.9%) |
| Sep 2022 | - | $12.56M(+11.0%) | $51.01M(+3.0%) |
| Jun 2022 | - | $11.32M(-24.3%) | $49.52M(+1.9%) |
| Mar 2022 | - | $14.96M(+22.9%) | $48.59M(+7.6%) |
| Dec 2021 | $45.17M(+14.2%) | $12.17M(+10.0%) | $45.17M(-0.1%) |
| Sep 2021 | - | $11.07M(+6.5%) | $45.22M(+5.0%) |
| Jun 2021 | - | $10.39M(-9.9%) | $43.06M(+2.2%) |
| Mar 2021 | - | $11.53M(-5.7%) | $42.13M(+6.5%) |
| Dec 2020 | $39.56M(+15.7%) | $12.23M(+37.3%) | $39.56M(+4.3%) |
| Sep 2020 | - | $8.91M(-5.9%) | $37.92M(+3.9%) |
| Jun 2020 | - | $9.46M(+5.6%) | $36.51M(+3.2%) |
| Mar 2020 | - | $8.96M(-15.4%) | $35.38M(+3.5%) |
| Dec 2019 | $34.19M(+115.4%) | $10.59M(+41.4%) | $34.19M(+12.0%) |
| Sep 2019 | - | $7.49M(-10.1%) | $30.53M(+14.4%) |
| Jun 2019 | - | $8.34M(+7.3%) | $26.68M(+27.2%) |
| Mar 2019 | - | $7.77M(+12.2%) | $20.97M(+32.1%) |
| Dec 2018 | $15.88M(+117.3%) | $6.93M(+90.1%) | $15.88M(+43.6%) |
| Sep 2018 | - | $3.64M(+38.5%) | $11.06M(+22.7%) |
| Jun 2018 | - | $2.63M(-1.6%) | $9.01M(+11.1%) |
| Mar 2018 | - | $2.67M(+26.9%) | $8.11M(+11.1%) |
| Dec 2017 | $7.30M(-7.7%) | $2.11M(+31.6%) | $7.30M(+9.2%) |
| Sep 2017 | - | $1.60M(-7.4%) | $6.69M(+2.8%) |
| Jun 2017 | - | $1.73M(-7.3%) | $6.51M(-8.1%) |
| Mar 2017 | - | $1.87M(+24.9%) | $7.08M(-10.4%) |
| Dec 2016 | $7.91M(-8.0%) | $1.49M(+5.2%) | $7.91M(-9.9%) |
| Sep 2016 | - | $1.42M(-38.4%) | $8.78M(-5.9%) |
| Jun 2016 | - | $2.31M(-14.3%) | $9.33M(-0.2%) |
| Mar 2016 | - | $2.69M(+14.0%) | $9.35M(+8.7%) |
| Dec 2015 | $8.60M | $2.36M(+19.5%) | $8.60M(+9.7%) |
| Sep 2015 | - | $1.97M(-14.9%) | $7.84M(+10.6%) |
| Jun 2015 | - | $2.32M(+19.4%) | $7.08M(+25.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $1.94M(+21.4%) | $5.66M(+26.4%) |
| Dec 2014 | $4.47M(+102.0%) | $1.60M(+30.8%) | $4.47M(+27.4%) |
| Sep 2014 | - | $1.22M(+37.2%) | $3.51M(+28.6%) |
| Jun 2014 | - | $891.20K(+17.3%) | $2.73M(+15.7%) |
| Mar 2014 | - | $759.70K(+18.9%) | $2.36M(+6.6%) |
| Dec 2013 | $2.21M(-13.5%) | $638.80K(+44.7%) | $2.21M(-5.2%) |
| Sep 2013 | - | $441.40K(-15.4%) | $2.34M(-7.4%) |
| Jun 2013 | - | $521.50K(-14.9%) | $2.52M(-0.5%) |
| Mar 2013 | - | $613.10K(-19.4%) | $2.54M(+31.9%) |
| Dec 2012 | $2.56M(>+9900.0%) | $760.70K(+21.0%) | $1.92M(+65.4%) |
| Sep 2012 | - | $628.90K(+17.6%) | $1.16M(+117.6%) |
| Jun 2012 | - | $534.60K(>+9900.0%) | $534.60K(>+9900.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $2.21M(>+9900.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2006 | - | $0.00 | $0.00 |
| Dec 2005 | $0.00(0.0%) | - | - |
| Dec 2004 | $0.00(0.0%) | - | - |
| Dec 2003 | $0.00(0.0%) | - | - |
| Dec 2002 | $0.00 | - | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual SG&A?
- What is the all-time high annual SG&A for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual SG&A year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. TTM SG&A year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual SG&A?
The current annual SG&A of CPRX is $0.00
What is the all-time high annual SG&A for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual SG&A is $120.94M
What is Catalyst Pharmaceuticals, Inc. annual SG&A year-on-year change?
Over the past year, CPRX annual SG&A has changed by -$120.94M (-100.00%)
What is Catalyst Pharmaceuticals, Inc. quarterly SG&A?
The current quarterly SG&A of CPRX is $39.26M
What is the all-time high quarterly SG&A for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly SG&A is $41.86M
What is Catalyst Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
Over the past year, CPRX quarterly SG&A has changed by +$2.53M (+6.89%)
What is Catalyst Pharmaceuticals, Inc. TTM SG&A?
The current TTM SG&A of CPRX is $1.25B
What is the all-time high TTM SG&A for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high TTM SG&A is $1.25B
What is Catalyst Pharmaceuticals, Inc. TTM SG&A year-on-year change?
Over the past year, CPRX TTM SG&A has changed by +$1.11B (+766.75%)